Skip to content
  • News
  • Science
  • Diseases
    • Systemic Lupus Erythematosus​
    • Dermatomyositis​
    • Sjögren’s syndrome
    • Monogenic Interferonopathies
  • Leadership
  • Investors
  • Partners
  • Contact
Menu
  • News
  • Science
  • Diseases
    • Systemic Lupus Erythematosus​
    • Dermatomyositis​
    • Sjögren’s syndrome
    • Monogenic Interferonopathies
  • Leadership
  • Investors
  • Partners
  • Contact
  • News
  • March 8, 2021

Annegret Van der Aa, PhD joins Ermium Therapeutics

Ermium Therapeutics strengthen its leadership team with the appointment of Annegret Van der Aa as CSO/CDO.
Press release
PrevPreviousLaurent Audoly, PhD, President and CEO of Parthenon Therapeutics, as non executive director of Ermium Therapeutics
NextKristof Van Emelen, PhD, joins Ermium Therapeutics as Head of Medicinal ChemistryNext

Share

Linkedin

About Us

  • Leadership
  • Investors
  • Partners
  • News

Science

  • Our Science
  • Targeted Diseases
  • Systemic Lupus Erythematosus
  • Dermatomyositis
  • Sjögren’s syndrome
  • Monogenic Interferonopathies

Support & contact

  • Cookie Policy
  • Legal Notice
  • Contact Us
  • Data privacy

Ermium Therapeutics © 2023 All Rights Reserved

Design by Cédric Adam

Manage Cookie Consent
We use cookies to optimize our website and our services.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}
  • News
  • Science
  • Diseases
    • Systemic Lupus Erythematosus​
    • Dermatomyositis​
    • Sjögren’s syndrome
    • Monogenic Interferonopathies
  • Leadership
  • Investors
  • Partners
  • Contact
close